Neurocrine Biosciences, Inc. (FRA:NB3)
129.20
-0.80 (-0.62%)
At close: Dec 4, 2025
Neurocrine Biosciences Employees
Neurocrine Biosciences had 1,800 employees as of December 31, 2024. The number of employees increased by 400 or 28.57% compared to the previous year.
Employees
1,800
Change (1Y)
400
Growth (1Y)
28.57%
Revenue / Employee
€1,270,258
Profits / Employee
€202,658
Market Cap
13.19B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Neurocrine Biosciences News
- 22 days ago - Northern Data AG (NDTAF) Rumble Inc., Tether Limited - M&A Call - Slideshow - Seeking Alpha
- 22 days ago - Rumble: AI Cloud Inflection - Seeking Alpha
- 25 days ago - Northern Data AG (NDTAF) M&A Call Transcript - Seeking Alpha
- 25 days ago - Rumble Advances Bid To Acquire Northern Data To Boost Cloud Computing Capabilities - Benzinga
- 25 days ago - Tether Invests $150M in Rumble's AI Ambitions with GPU Power - Wallstreet:Online
- 25 days ago - Rumble Snaps Up AI Powerhouse Northern Data - Wallstreet:Online
- 25 days ago - EQS-Adhoc: Northern Data Enters into a Business Combination Agreement with Rumble - Wallstreet:Online
- 25 days ago - EQS-Adhoc: Northern Data schließt Business Combination Agreement mit Rumble ab • news - Onvista